Paradigm Capital Management Inc. NY Sells 70,600 Shares of Orthofix Medical Inc. (NASDAQ:OFIX)

Paradigm Capital Management Inc. NY decreased its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 2.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,485,900 shares of the medical device company's stock after selling 70,600 shares during the period. Orthofix Medical accounts for about 2.0% of Paradigm Capital Management Inc. NY's investment portfolio, making the stock its 15th largest holding. Paradigm Capital Management Inc. NY owned 6.51% of Orthofix Medical worth $43,404,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in OFIX. Juniper Investment Company LLC grew its holdings in Orthofix Medical by 123.5% during the fourth quarter. Juniper Investment Company LLC now owns 1,937,249 shares of the medical device company's stock worth $33,824,000 after acquiring an additional 1,070,656 shares during the period. JPMorgan Chase & Co. boosted its holdings in Orthofix Medical by 244.1% during the fourth quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company's stock worth $5,070,000 after buying an additional 205,972 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Orthofix Medical by 31.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 659,475 shares of the medical device company's stock worth $11,515,000 after buying an additional 159,177 shares during the last quarter. Emerald Mutual Fund Advisers Trust grew its position in Orthofix Medical by 35.4% in the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 503,802 shares of the medical device company's stock worth $8,796,000 after buying an additional 131,653 shares during the last quarter. Finally, Boone Capital Management LLC increased its holdings in shares of Orthofix Medical by 13.6% in the fourth quarter. Boone Capital Management LLC now owns 1,057,313 shares of the medical device company's stock valued at $18,461,000 after buying an additional 126,806 shares in the last quarter. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Orthofix Medical news, major shareholder Engine Capital Management, Lp acquired 100,000 shares of Orthofix Medical stock in a transaction dated Wednesday, May 7th. The stock was bought at an average cost of $12.31 per share, with a total value of $1,231,000.00. Following the completion of the transaction, the insider now owns 3,544,807 shares of the company's stock, valued at $43,636,574.17. The trade was a 2.90% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Massimo Calafiore bought 10,000 shares of the business's stock in a transaction that occurred on Friday, May 9th. The shares were bought at an average price of $12.54 per share, with a total value of $125,400.00. Following the completion of the purchase, the chief executive officer now owns 234,603 shares in the company, valued at approximately $2,941,921.62. The trade was a 4.45% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold 8,475 shares of company stock worth $128,065 in the last quarter. 1.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

OFIX has been the topic of a number of recent research reports. Canaccord Genuity Group restated a "buy" rating and issued a $24.00 target price on shares of Orthofix Medical in a report on Wednesday, February 26th. Roth Mkm restated a "buy" rating and set a $22.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, Wall Street Zen cut shares of Orthofix Medical from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th.

Orthofix Medical Stock Performance

Shares of OFIX stock traded down $0.13 during trading on Friday, reaching $11.10. The company had a trading volume of 572,966 shares, compared to its average volume of 267,576. Orthofix Medical Inc. has a one year low of $10.50 and a one year high of $20.73. The company has a market capitalization of $433.14 million, a PE ratio of -3.55 and a beta of 0.87. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. The firm's 50 day simple moving average is $13.89 and its two-hundred day simple moving average is $16.58.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.